It was reported that the patient gets skin rash all over his body when the stimulation is activated.The patient requested an explant of the device.The device was explanted successfully with no report of patient harm or injury.The patient reported that the skin rash occurred immediately upon activating the reactiv8 system.There was no medical intervention performed for the rash.According to the patient, the skin rash is exclusively in the back, lasts several days, and occurs every stimulation.The patient confirmed stimulation was not painful.The patient was activated 14 days after the implantation of the device ((b)(6) 2023).The mainstay medical therapy manager and the physician did not notice a rash, and the patient did not complaint of a rash or other issues at the time of activation.A review of the device log, the patient only performed one session per day on average, predominantly delivered in the evening.The device operated as expected.It was not confirmed that the patient experienced a skin rash during stimulation because the patient stopped using the device on (b)(6) 2023.All impedances were stable throughout.After explant, the device was received for evaluation.The implantable pulse generator and the stimulation leads performed normally during testing.A review of the device manufacturing and sterilization revealed no non-conformances that would have contributed to the skin rash reported by the patient.
|